Aurentz Vincent Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Aurentz Vincent.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Aurentz Vincent. Aurentz Vincent is Executive VP and CBO in ARENA PHARMACEUTICALS INC ($ARNA) and Chief Business Officer in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
Latest Insider Trading Transactions of Aurentz Vincent
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Grant | A | 0.00 | 6,660 | 0 | 33,660 | 27 K to 33.7 K (+24.67 %) |
| Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Grant | A | 0.00 | 6,660 | 0 | 33,660 | 27 K to 33.7 K (+24.67 %) |
| Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 35.60 | 24 | 854 | 94,976 | |
| Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 14.60 | 2,500 | 36,500 | 77,000 | |
| Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 85.00 | 2,524 | 214,540 | 27,000 | 29.5 K to 27 K (-8.55 %) |
| Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 35.60 | 24 | 854 | 29,524 | 29.5 K to 29.5 K (+0.08 %) |
| Feb 18 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 14.60 | 2,500 | 36,500 | 29,500 | 27 K to 29.5 K (+9.26 %) |
| Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
| Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 0.00 | 18,000 | 0 | 27,000 | 9 K to 27 K (+200.00 %) |
| Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
| Jan 11 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 0.00 | 18,000 | 0 | 27,000 | 9 K to 27 K (+200.00 %) |
| Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 0.00 | 9,000 | 0 | 18,000 | |
| Nov 30 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
| Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 35.60 | 5,000 | 178,000 | 95,000 | |
| Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 14.60 | 10,000 | 146,000 | 79,500 | |
| Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 17.10 | 10,000 | 171,000 | 45,000 | |
| Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 65.00 | 25,000 | 1,625,023 | 0 | 25 K to 0 (-100.00 %) |
| Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 35.60 | 5,000 | 178,000 | 25,000 | 20 K to 25 K (+25.00 %) |
| Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 14.60 | 10,000 | 146,000 | 20,000 | 10 K to 20 K (+100.00 %) |
| Jun 04 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 17.10 | 10,000 | 171,000 | 10,000 | 0 to 10 K |
| Feb 07 2020 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 50.00 | 9,000 | 450,000 | 0 | 9 K to 0 (-100.00 %) |
| Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 0.00 | 9,000 | 0 | 27,000 | |
| Oct 16 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 35.60 | 30,000 | 1,068,000 | 100,000 | |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 35.60 | 30,000 | 1,068,000 | 100,000 | |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 14.60 | 10,000 | 146,000 | 89,500 | |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 14.60 | 10,000 | 146,000 | 89,500 | |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 17.10 | 25,000 | 427,500 | 55,000 | |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | M | 17.10 | 25,000 | 427,500 | 55,000 | |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 51.23 | 20,328 | 1,041,501 | 0 | 20.3 K to 0 (-100.00 %) |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 51.23 | 20,328 | 1,041,501 | 0 | 20.3 K to 0 (-100.00 %) |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 50.48 | 44,672 | 2,255,199 | 20,328 | 65 K to 20.3 K (-68.73 %) |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Sell | S | 50.48 | 44,672 | 2,255,199 | 20,328 | 65 K to 20.3 K (-68.73 %) |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 35.60 | 30,000 | 1,068,000 | 65,000 | 35 K to 65 K (+85.71 %) |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 35.60 | 30,000 | 1,068,000 | 65,000 | 35 K to 65 K (+85.71 %) |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 14.60 | 10,000 | 146,000 | 35,000 | 25 K to 35 K (+40.00 %) |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 14.60 | 10,000 | 146,000 | 35,000 | 25 K to 35 K (+40.00 %) |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 17.10 | 25,000 | 427,500 | 25,000 | 0 to 25 K |
| Sep 10 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Buy | M | 17.10 | 25,000 | 427,500 | 25,000 | 0 to 25 K |
| Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
| Jan 08 2019 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 40.94 | 75,000 | 3,070,500 | 75,000 | |
| Jan 22 2018 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 35.60 | 130,000 | 4,628,000 | 130,000 | |
| Feb 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 1.46 | 995,000 | 1,452,700 | 995,000 | |
| Aug 15 2016 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 1.71 | 800,000 | 1,368,000 | 800,000 | |
| Aug 15 2016 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 1.71 | 800,000 | 1,368,000 | 800,000 | |
| May 31 2016 | CRXX | EPIRUS Biopharmace ... | Aurentz Vincent | Chief Business Offi ... | Option Exercise | A | 0.00 | 230,000 | 0 | 230,000 | |
| Dec 21 2015 | CRXX | EPIRUS Biopharmace ... | Vincent Aurentz | Chief Business Offi ... | Buy | P | 3.43 | 2,200 | 7,546 | 2,200 | 0 to 2.2 K |
| Dec 11 2015 | CRXX | EPIRUS Biopharmace ... | Vincent Aurentz | Chief Business Offi ... | Buy | P | 3.85 | 2,800 | 10,780 | 2,800 | 0 to 2.8 K |
| Nov 10 2015 | CRXX | EPIRUS Biopharmace ... | Vincent Aurentz | Chief Business Offi ... | Option Exercise | A | 5.21 | 219,487 | 1,143,527 | 219,487 |
Page: 1